RxDoctor Payments Data

Julie Messina, PA

Physician Assistant · Lone Tree, CONPI 1790811065

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Springworks Therapeutics, Inc. at 26.1% of the total. 2025 is the largest year on record at $9,177, 3.2 times the $2,828 reported in 2021. Among physician assistant clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,124in general payments, 2019–2025

Across 80 payments — averaging $164.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Springworks Therapeutics, Inc.$3K
  • Stemline Therapeutics Inc.$3K
  • Incyte Corporation$3K
  • Johnson & Johnson$1K
  • Novartis$780
  • Daiichi Sankyo Inc.$650
  • plus $949 from 13 others

What the payments were for

  • Consulting fees$4,90837%
  • Speaking & faculty fees$5,74844%
  • Travel & lodging$671%
  • Food & beverage$2,02415%
  • Education$3783%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,124 in reported general payments places this provider in the 95th percentile of 2,849 physician assistant providers in Colorado.

See all physician assistant providers in Colorado

Medicare billing

Part B allowed, 2024
$6,169
Medicare patients
49
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban35$20,939
Anastrozole33$313
Prochlorperazine Maleate19$240
Ondansetron Hcl19$237
Letrozole11$208
Alendronate Sodium11$46
Lorazepam12$31
Levofloxacin12$30

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$164$20,93935 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,849 physician assistant providers in Colorado.

Other physician assistant in Lone Tree

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →